The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.
作者信息
Hassanein Tarek, Shiffman Mitchell L, Zein Nizar N
机构信息
University of California, San Diego.
出版信息
Gastroenterol Hepatol (N Y). 2007 Jun;3(6 Suppl 20):4-32.
Abstract
摘要
相似文献
1
The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.慢性丙型肝炎治疗失败的实际管理：难治性患者的当前研究与管理选择综述
Gastroenterol Hepatol (N Y). 2007 Jun;3(6 Suppl 20):4-32.
2
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.增强型体外反搏（EECP）：基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 1.
3
A Practical Approach to Refractory Chronic Rhinosinusitis.难治性慢性鼻-鼻窦炎的实用治疗方法
Otolaryngol Clin North Am. 2017 Feb;50(1):183-198. doi: 10.1016/j.otc.2016.08.014.
4
Resistance to hepatitis C virus. Implications and therapeutic options.
Gastroenterol Hepatol. 2017 Aug-Sep;40(7):484-494. doi: 10.1016/j.gastrohep.2017.04.007. Epub 2017 Jun 22.
5
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.欧洲艾滋病临床学会（EACS）关于HIV感染成人慢性乙型和丙型肝炎合并感染临床管理与治疗的指南。
HIV Med. 2008 Feb;9(2):82-8. doi: 10.1111/j.1468-1293.2007.00535.x.
6
Management of Hepatitis C: A Practical Primer for Nurses.
Gastroenterol Nurs. 2020 Jan/Feb;43(1):22-27. doi: 10.1097/SGA.0000000000000430.
7
New hepatitis C virus therapies: drug classes and metabolism, drug interactions relevant in the transplant settings, drug options in decompensated cirrhosis, and drug options in end-stage renal disease.新型丙型肝炎病毒疗法：药物类别与代谢、移植环境中相关的药物相互作用、失代偿期肝硬化的药物选择以及终末期肾病的药物选择。
Curr Opin Organ Transplant. 2015 Jun;20(3):235-41. doi: 10.1097/MOT.0000000000000198.
8
Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.老年血液透析患者的病毒性肝炎：当前的预防和管理策略
Drugs Aging. 2008;25(10):823-40. doi: 10.2165/00002512-200825100-00002.
9
Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease.慢性肾脏病中慢性乙型和丙型肝炎的当前管理
Adv Chronic Kidney Dis. 2015 Sep;22(5):352-60. doi: 10.1053/j.ackd.2015.06.008.
10
Treatment of chronic viral hepatitis in patients with renal disease.肾病患者慢性病毒性肝炎的治疗
Gastroenterol Clin North Am. 2004 Sep;33(3):655-70, xi. doi: 10.1016/j.gtc.2004.04.011.
引用本文的文献
1
Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome.比较直接作用抗病毒治疗丙型肝炎前后的肝活检结果，并与临床结果相关。
Sci Rep. 2021 Jul 15;11(1):14506. doi: 10.1038/s41598-021-93881-7.
2
Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong.香港直接作用抗病毒药物治疗慢性丙型肝炎病毒感染的预算影响和成本效益分析。
Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1801-1809. doi: 10.1007/s10096-017-2995-7. Epub 2017 May 17.
本文引用的文献
1
Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3.
Am J Gastroenterol. 2007 Apr;102(4):761-6. doi: 10.1111/j.1572-0241.2007.01092.x. Epub 2007 Feb 23.
2
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.慢性丙型肝炎患者再治疗期间降低聚乙二醇干扰素α-2a和利巴韦林剂量的影响
Gastroenterology. 2007 Jan;132(1):103-12. doi: 10.1053/j.gastro.2006.11.011. Epub 2006 Nov 11.
3
Hepatitis C in HIV-positive patients--treatment and liver disease outcomes.
J Clin Gastroenterol. 2007 Jan;41(1):75-87. doi: 10.1097/01.mcg.0000225592.16448.f3.
4
Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment.利巴韦林剂量减少对完成聚乙二醇干扰素α-2a/利巴韦林治疗的丙型肝炎病毒1型患者的影响。
Clin Gastroenterol Hepatol. 2007 Jan;5(1):124-9. doi: 10.1016/j.cgh.2006.10.008. Epub 2006 Dec 28.
5
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.疾病严重程度对慢性丙型肝炎抗病毒治疗结局的影响：来自HALT-C试验的经验教训。
Hepatology. 2006 Dec;44(6):1675-84. doi: 10.1002/hep.21440.
6
Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus.艾滋病毒和丙型肝炎病毒合并感染患者的抗逆转录病毒药物治疗考量
AIDS Patient Care STDS. 2006 Oct;20(10):678-92. doi: 10.1089/apc.2006.20.678.
7
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.利巴韦林对1型丙型肝炎患者接受聚乙二醇化干扰素α-2a加利巴韦林治疗反应的影响。
Gastroenterology. 2006 Oct;131(4):1040-8. doi: 10.1053/j.gastro.2006.07.022. Epub 2006 Jul 24.
8
Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C.聚乙二醇干扰素和利巴韦林治疗慢性丙型肝炎期间精神科副作用对依从性和持续病毒学应答的影响
Aliment Pharmacol Ther. 2006 Oct 15;24(8):1223-30. doi: 10.1111/j.1365-2036.2006.03107.x.
9
Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C.老年患者在丙型肝炎抗病毒治疗期间发生血细胞减少的风险更高。
Can J Gastroenterol. 2006 Sep;20(9):589-92. doi: 10.1155/2006/357259.
10
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.聚乙二醇干扰素和利巴韦林治疗非裔美国人和高加索裔美国人1型丙型肝炎患者。
Gastroenterology. 2006 Aug;131(2):470-7. doi: 10.1053/j.gastro.2006.06.008.
Zotero 插件